SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMUNE NETWORK RESEARCH (VSE:IMM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael R. Dunsford who wrote (68)6/23/1998 1:49:00 PM
From: John Fairchild  Read Replies (1) of 134
 
I spoke with Victor Jones yesterday and yes this is good news.

The researchers are pleased with the testing and the animals are doing very well. They want to get as much information from this study group as possible and that is why they are looking at another injection. All plasma and tissue samples are stored for testing in Sept.
The testing of the samples are done all at the same time to gather consistent assay results with an established base line case (or something like that).

As far as testing another species, they know the monkey's show no ill effects from the 1F7 but they need to establish that another species like a rat will also tolerate 1F7. A cross check for Toxicity.

Human testing may begin as early as this year.

The researchers are very encouraged with what they are seeing and are looking to do further research with 1F7 into broader applications.

John.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News